Trials / Completed
CompletedNCT01009697
Dose Linearity Study of Codeine Sulfate Under Fasted Conditions
A Single Dose, 3-Period, 3-Treatment, 6-Sequence, 3-Way Crossover Study of the Dose Linearity of Codeine Sulfate Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to examine the dose linearity of Roxane Laboratories' 15 mg, 30 mg, and 60 mg codeine sulfate tablets under fasted conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Codeine Sulfate | 15 mg, 30 mg, and 60 mg tablets |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2009-11-09
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01009697. Inclusion in this directory is not an endorsement.